Tradestie Institutional Equity Comparison Engine

CASI vs IMMX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IMMX Overall Edge

IMMX Captures Institutional Edge (2โ€“1 Pillars ยท 8โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Immix Biopharma, Inc. Common Stock (IMMX) driven by superior Growth & Margin, Momentum & Technical while CASI counters with relative strength in Options & Structure. Fundamentally, CASI trades at N/M Forward P/E with -333.1% operating margin (-60.5% YoY revenue) versus IMMX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, CASI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against IMMX sits in BREAKDOWN (30th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CASI N/M vs IMMX N/M Fwd P/E
Growth & Margin Winner IMMX
Op Margin -333.1% vs 0.0% ยท YoY -60.5% vs +0.0%
Momentum & Technical Winner IMMX
1Y -91.4% vs +64.5% ยท 52W Pos 0% vs 28%
Options & Structure Winner CASI
UNCLASSIFIED (N/A IV) vs BREAKDOWN (30th %ile IV)
CASI NASDAQ
CASI Pharmaceuticals, Inc. Ordinary Shares
Pharmaceutical Preparations
$0.21
-74.06% 1D
Market Cap $12.4M
1M Return -78.83%
1Y Return -91.43%
Forward P/E N/M
Unified AI Score
44.7 / 100 HOLD
Tech 40.0 Fund 44.0 Flow 50.0 Mom 44.0
IMMX NASDAQ
Immix Biopharma, Inc. Common Stock
Pharmaceutical Preparations
$6.96
-1.14% 1D
Market Cap $590.0M
1M Return -16.65%
1Y Return +64.54%
Forward P/E N/M
Unified AI Score
50.6 / 100 HOLD
Tech 38.0 Fund 64.0 Flow 67.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CASI -91.43% IMMX +64.54% Spread: +189.57 pp (IMMX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CASI TTM Op. Margin: -333.1% IMMX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CASI vs IMMX. Trailing 12-month operating profitability (CASI -333.1% vs IMMX 0.0%) and valuation multiples (CASI N/M vs IMMX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CASI (0) vs IMMX (8)
Institutional Metric CASI IMMX Criterion Row Winner
Market Capitalization Scale $12.4M $590.0M Larger Scale IMMX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -60.5% +0.0% Higher Growth IMMX
Operating Margin (TTM) Profitability -333.1% 0.0% Higher Margin IMMX
Net Profit Margin Profitability -184.0% 0.0% Higher Margin IMMX
Return on Equity (ROE) Capital Efficiency -1094.5% -27.0% Higher ROE IMMX
52-Week Range Position Momentum 0% ($0โ€“$3) 28% ($4โ€“$15) Stronger Trend IMMX
Beta / 30D Volatility Risk Regime 0.95ฮฒ ยท 240% Vol 1.65ฮฒ ยท 76% Vol Lower Realized Risk IMMX
Unified Institutional Score Composite Signal 44.7 / 100 (HOLD) 50.6 / 100 (HOLD) Higher Composite IMMX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CASI vs IMMX Buy Guide
CASI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CASI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IMMX BREAKDOWN
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 30th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live IMMX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CASI nor IMMX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.